Asthma Drug Xolair Linked to Severe Brain, Heart Issues, Pharmaceutical Lawyers at Baron and Budd Report
03 March 2015 - 9:49AM
Business Wire
Class Action XOLAIR Lawsuit Underway
Xolair, a drug used to treat allergic asthma in adults and
children 12 years and older, has been linked to significant health
issues such as mini-strokes, heart attacks and blood clots, the
national law firm of Baron and Budd reports. In September, 2014,
The United States Food and Drug Administration (FDA) determined
that a warning label should be added to the drug to inform patients
of the potential dangers.
Xolair is the brand name of the drug omalizumab, which was
developed from DNA extracted from the Chinese hamster. Developers
modified the DNA to help supplement the genetic material normally
produced in a patient’s immune system. The injectable medication is
designed to treat those who test positive for allergens in the air
that occur year-round and suffer recurrent asthma as a result.
People who do not typically respond well to traditional asthma
medications are considered candidates for the drug.
However, several potentially serious health issues have been
associated with the use of Xolair. Studies have shown patients may
be at risk for blood clots in the lungs and veins, transient
ischemic attacks (also referred to as mini-strokes) and
anaphylaxis, an allergic issue that can make breathing extremely
difficult. According to researchers, patients are not only at risk
immediately after taking the drug, but may also experience problems
up to a year after stopping their treatment.
“There has not been a recall of Xolair as of this date, but
evidence shows the drug can be extremely dangerous for patients,”
said Russell Budd, president and managing shareholder of the
national law firm of Baron and Budd. “We want to help people
who have been injured by these injections
to receive compensation."
Plaintiffs in the Xolair class action lawsuit believe that
Genentech and Novartis, the injection’s manufacturer, knew about
its serious risks but failed to provide adequate warnings, thereby
putting many people at risk.
If you or someone close to you took Xolair and suffered problems
related to blood vessels in the heart or brain, please
contact Baron & Budd’s Xolair
lawyers at info@baronandbudd.com or
1.866.472.9108.
ABOUT BARON & BUDD, P.C.
The law firm of Baron & Budd, P.C., with offices in Dallas,
Baton Rouge, Austin and Los Angeles, is a nationally recognized law
firm with a nearly 40 year history of "Protecting What's Right" for
people, communities and businesses harmed by negligence. Baron
& Budd's size and resources enable the firm to take on large
and complex cases. The firm represents individuals and government
and business entities in areas as diverse as dangerous
pharmaceuticals and medical devices, environmental contamination,
the Gulf oil spill, financial fraud, overtime violations, deceptive
advertising, automotive defects, trucking accidents, nursing home
abuse, and asbestos-related illnesses such as mesothelioma.
Baron and Budd, P.C.Susan Jones Knape,
214-629-0596sknape@baronbudd.comorBradley Bowen,
214-523-6260bbowen@baronbudd.com